AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Zometa significantly reduces bone complications.(in breast cancer patients)

Women's Health Weekly

| January 09, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JAN 9 - (NewsRx.com & NewsRx.net) -- Zometa (zoledronic acid for injection) significantly reduced the risk of developing a skeletal-related event (SRE) when compared to pamidronate disodium for injection (Aredia) in advanced breast cancer patients who were treated for up to 24 months, according to data presented at the San Antonio Breast Cancer Symposium.

These SREs include, among others, pathologic fractures, a need for radiation or surgery to bone, spinal cord compression and hypercalcemia. An intravenous bisphosphonate, Zometa is the first therapy of its kind to demonstrate efficacy in treating bone complications across a broad range of tumor types such as breast, prostate, lung and renal cell cancers. Further, Zometa offers patients, nurses and clinicians a convenient 4 mg, 15-minute infusion time.

"Bone metastases and their complications can be severely debilitating for advanced breast cancer patients. These new longer-term data suggest that Zometa offers these patients an effective and convenient treatment that reduces their risk of developing these complications," said Robert E. Coleman, MD, lead investigator and head of the Cancer Research Centre, University of Sheffield, England.

In this study, a multiple-event analysis demonstrated that breast cancer patients treated with Zometa 4 mg in a 15-minute infusion had a lower risk of developing skeletal complications (p=0.025) after 2 years of treatment, compared with those treated with pamidronate disodium for ...

Related articles from newspapers, magazines, journals, and more
Genomic Health Announces Data Confirming Manual Microdissection of Biopsy...
Press release article from: PR Newswire October 9, 2009 700+ words
...R) Result in Japanese Breast Cancer Patients -- -- Both Studies Presented...recurrence for early-stage breast cancer patients. The Oncotype DX assay...than 4,000 breast cancer breast cancer patients worldwide, including a...
STUDIES CONFIRM INCREASED SURVIVAL FOR BREAST CANCER PATIENTS TREATED WITH...
Press release article from: Business Wire April 18, 1995 700+ words
...against breast cancer. "Breast cancer patients often live in fear that...negative, ER-positive breast cancer patients showed that therapy with...Nolvadex therapy was given to breast cancer patients for less than 2 years...
Young breast cancer patients concerned with therapy's effect on fertility.
Magazine article from: Women's Health Weekly November 4, 2004 700+ words
...Survival Coalition (YSC), a breast cancer patient advocacy group...or younger at the time of breast cancer diagnosis. Fifty-seven...fertility in women treated for breast cancer. "Young cancer patients have very few options for...
Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton...
Press release article from: Business Wire December 15, 2007 700+ words
...bone loss for women with breast cancer is a genuine concern and...therapy in postmenopausal breast cancer patients, already in a state of...induced bone loss (in breast cancer and prostate cancer patients) and for its potential...
The LL genotype in breast cancer patients may be associated with poor prognosis.
Magazine article from: Women's Health Weekly January 29, 2004 700+ words
...At the same time, among breast cancer patients, the Leu allele has been...researchers stated. Compared with breast cancer patients with VV or VL genotypes...breast cancer. However, in breast cancer patients, the LL genotype may be...
Ms. Fitness Magazine: Over Two-Thirds of Recurrent Breast Cancer Patients Had...
Press release article from: PR Newswire October 10, 2006 700+ words
...Control for Recurrent Breast Cancer Patients SALT LAKE CITY, Oct...estimated 10,000 breast cancer patients each year who experience...patients with recurrent breast cancer. "For the many cancer patients who experience recurrence...
Wrapped in 'Spirit Shawls' for the Holidays; Breast Cancer Patients Receive...
Press release article from: PR Newswire December 13, 2000 700+ words
...Cancer will be presenting breast cancer patients with special holiday gifts...Indigent and Underserved breast cancer patients in Los Angeles County...holidays a little easier for 50 breast cancer patients who are receiving chemotherapy...
Peptides inducing immune responses in breast cancer patients identified.
Newspaper article from: Drug Week September 3, 2004 700+ words
...responses in HLA-A24 positive breast cancer patients. "HRE2/neu-specific...responses are often detected in breast cancer patients, but identification of...immunity in HLA-A24+ breast cancer patients," investigators in Japan...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA